Tag Archives: Rheumatoid

Abbvie’s Rinvoq matches BMS’ Orencia in head-to-head rheumatoid arthritis trial

With megablockbuster Humira on the decline, AbbVie is hoping for big things from its next-gen JAK inhibitor Rinvoq. Now, in a head-to-head rheumatoid arthritis battle with Bristol Myers Squibb’s blockbuster Orencia, Rinvoq has come out on top. Rinvoq matched Bristol’s Orencia in easing rheumatoid arthritis patients’ symptoms at the 12-week mark and bested its older rival in patient remission rates, according to… Read More »

What if it not rheumatoid arthritis

6 Can the child be vaccinated? Dlugolecki was diagnosed with arthritic knees two weeks before riding in this year’s event. If there are IgM-antibodies to Borrelia burgdorferi found by Enzyme Immuno Assay, a confirmatory what if it not rheumatoid arthritis called Immunoblot or Western blot must be performed. Learn how to create a happy, healthy… Read More »

Where does rheumatoid arthritis affect

What Does Rheumatoid Arthritis Progression Look Like? The attack is not only directed at the joint but to many other parts where does rheumatoid arthritis affect the body. Adult-onset Still’s DiseaseAOSD changes a faint, salmon-colored skin rash and according to the Still’s Disease Information Center, up to 95 percent of people with AOSD have this… Read More »

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More »